BRM
MDT icon

Boston Research & Management’s Medtronic MDT Stock Holding History

Boston Research & Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.38M Buy
50,546
+1,508
+3% +$144K 1.04% 45
2025
Q4 		$4.71M Sell
49,038
-1,740
-3% -$169K 1.09% 42
2025
Q3 		$4.84M Buy
50,778
+281
+0.6% +$25.8K 1.07% 41
2025
Q2 		$4.4M Buy
50,497
+1,996
+4% +$169K 1.05% 46
2025
Q1 		$4.36M Sell
48,501
-2,367
-5% -$212K 1.08% 44
2024
Q4 		$4.06M Sell
50,868
-96
-0.2% -$8.31K 1% 47
2024
Q3 		$4.59M Buy
50,964
+2,477
+5% +$208K 1.08% 43
2024
Q2 		$3.82M Buy
48,487
+587
+1% +$48.1K 0.96% 51
2024
Q1 		$4.17M Buy
47,900
+804
+2% +$68.6K 1.03% 47
2023
Q4 		$3.88M Sell
47,096
-6,419
-12% -$489K 1.03% 46
2023
Q3 		$4.19M Buy
53,515
+515
+1% +$43.1K 1.24% 38
2023
Q2 		$4.67M Buy
53,000
+540
+1% +$46.5K 1.32% 33
2023
Q1 		$4.23M Buy
52,460
+4,265
+9% +$348K 1.26% 37
2022
Q4 		$3.75M Sell
48,195
-2,815
-6% -$228K 1.16% 41
2022
Q3 		$4.12M Buy
51,010
+3,550
+7% +$319K 1.4% 29
2022
Q2 		$4.26M Buy
47,460
+1,205
+3% +$122K 1.38% 33
2022
Q1 		$5.13M Buy
46,255
+1,277
+3% +$135K 1.49% 25
2021
Q4 		$4.65M Sell
44,978
-1,020
-2% -$118K 1.27% 34
2021
Q3 		$5.76M Buy
45,998
+300
+0.7% +$38.8K 1.72% 22
2021
Q2 		$5.67M Sell
45,698
-527
-1% -$66.2K 1.72% 22
2021
Q1 		$5.46M Buy
46,225
+1,885
+4% +$221K 1.76% 24
2020
Q4 		$5.19M Sell
44,340
-118
-0.3% -$13K 1.81% 23
2020
Q3 		$4.62M Sell
44,458
-1,212
-3% -$122K 1.81% 21
2020
Q2 		$4.19M Buy
45,670
+1,334
+3% +$128K 1.74% 22
2020
Q1 		$4M Sell
44,336
-280
-0.6% -$29.8K 2.01% 18
2019
Q4 		$5.06M Sell
44,616
-65
-0.1% -$7.13K 1.9% 17
2019
Q3 		$4.85M Sell
44,681
-230
-0.5% -$24K 1.92% 17
2019
Q2 		$4.37M Buy
44,911
+715
+2% +$65.3K 1.77% 25
2019
Q1 		$4.03M Sell
44,196
-540
-1% -$48.3K 1.68% 27
2018
Q4 		$4.07M Buy
44,736
+4,100
+10% +$383K 1.94% 19
2018
Q3 		$4M Sell
40,636
-430
-1% -$39.8K 1.83% 22
2018
Q2 		$3.52M Buy
41,066
+1,040
+3% +$86.9K 1.73% 25
2018
Q1 		$3.21M Buy
40,026
+1,370
+4% +$113K 1.64% 29
2017
Q4 		$3.12M Sell
38,656
-405
-1% -$32.4K 1.57% 33
2017
Q3 		$3.04M Buy
39,061
+1,676
+4% +$139K 1.55% 36
2017
Q2 		$3.32M Buy
37,385
+35
+0.1% +$2.95K 1.79% 24
2017
Q1 		$3.01M Buy
37,350
+2,030
+6% +$159K 1.64% 30
2016
Q4 		$2.52M Sell
35,320
-3,824
-10% -$300K 1.43% 37
2016
Q3 		$3.38M Sell
39,144
-20
-0.1% -$1.74K 1.95% 16
2016
Q2 		$3.4M Sell
39,164
-300
-0.8% -$24.3K 2.06% 9
2016
Q1 		$2.96M Sell
39,464
-870
-2% -$65.5K 1.84% 17
2015
Q4 		$3.1M Sell
40,334
-1,339
-3% -$101K 1.93% 13
2015
Q3 		$2.79M Buy
41,673
+94
+0.2% +$6.92K 1.84% 17
2015
Q2 		$3.08M Sell
41,579
-1,610
-4% -$123K 1.95% 14
2015
Q1 		$3.37M Sell
43,189
-1,002
-2% -$75.9K 2.14% 8
2014
Q4 		$3.19M Sell
44,191
-175
-0.4% -$12.2K 2% 11
2014
Q3 		$2.75M Buy
44,366
+900
+2% +$57.2K 1.85% 16
2014
Q2 		$2.77M Sell
43,466
-830
-2% -$50.4K 1.92% 13
2014
Q1 		$2.73M Buy
44,296
+1,130
+3% +$65.8K 2% 10
2013
Q4 		$2.48M Sell
43,166
-934
-2% -$53K 1.9% 14
2013
Q3 		$2.35M Sell
44,100
-290
-0.7% -$15.6K 1.98% 11
2013
Q2 		$2.28M Buy
+44,390
New +$2.19M 2.03% 11

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boston Research & Management's MDT Position: Q1 2026 in Review

Boston Research & Management increased its Medtronic (MDT) stake by 3.1% in Q1 2026, buying an estimated $144K and bringing the position to 50,546 shares worth $4.38M. The position accounts for 1.04% of the portfolio, ranked #45.

Boston Research & Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.76M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Boston Research & Management held 50,546 shares of Medtronic worth $4.38M as of Q1 2026.
  • Boston Research & Management bought 1,508 Medtronic shares in Q1 2026, an estimated $144K.
  • Medtronic made up 1.04% of Boston Research & Management's portfolio in Q1 2026, its #45 holding.
  • Boston Research & Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Boston Research & Management's Medtronic position peaked at $5.76M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Boston Research & Management's 13F filing for Q1 2026, filed 10 Apr 2026.